API Gallery

The Sodium DNA market is projected to grow at a CAGR of 6.1% from 2025 to 2035, driven by rising demand for regenerative skin therapies, expanding applications in wound healing, and increased use in anti-aging and aesthetic medicine.
The Sodium Formaldehyde Sulfoxylate market is projected to grow at a CAGR of 5.4% from 2025 to 2035, driven by increasing demand for textile processing agents, rising use in polymerization and dyeing applications, and expanding industrial-scale bleaching operations.
The Sodium Fusidate market is projected to grow at a CAGR of 5.4% from 2025 to 2035, driven by increasing demand for textile processing agents, rising use in polymerization and dyeing applications, and expanding industrial-scale bleaching operations.
The Sodium Gluconate market is projected to grow at a CAGR of 7.0% from 2025 to 2035, driven by increasing demand across construction, water treatment, food and pharmaceutical industries, and growing use as a chelating and sequestrant agent.
The Sodium Glycerophosphate market is projected to grow at a CAGR of 5.6% from 2025 to 2035, driven by increasing demand for parenteral nutrition products, rising prevalence of malnutrition and critical illnesses, and expanding applications in the pharmaceutical and food industries.
The Sodium Hyaluronate market is projected to grow at a CAGR of 7.2% from 2025 to 2035, driven by increasing demand for parenteral nutrition products, rising prevalence of malnutrition and critical illnesses, and expanding applications in the pharmaceutical and food industries.
The Sodium Hydrogen Carbonate market is projected to grow at a CAGR of 4.1% from 2025 to 2035, driven by increasing demand for parenteral nutrition products, rising prevalence of malnutrition and critical illnesses, and expanding applications in the pharmaceutical and food industries.
The Sodium Iodide market is projected to grow at a CAGR of 5.7% from 2025 to 2035, driven by increasing demand in nuclear medicine, expanding use in diagnostic imaging, and growing applications in nutritional supplementation and pharmaceuticals.
The Nafamostat market is projected to grow at a CAGR of 8.1% from 2025 to 2035, driven by its increasing use in the treatment of acute pancreatitis, chronic pancreatitis, and COVID-19-related complications.
The Naftifine Hydrochloride (Naftifine HCl) market is projected to grow at a CAGR of 4.4% from 2025 to 2035, driven by increasing prevalence of dermatophyte infections such as athlete’s foot, ringworm, and jock itch, alongside growing demand for topical antifungal treatments.
The Nalbuphine Hydrochloride market is projected to grow at a CAGR of 6.2% from 2025 to 2035, fueled by increasing demand for effective, safer opioid analgesics in surgical, obstetric, and trauma-related pain management.

Search from 10,000 + API reports

How can we help you?

Reach out to discuss how our team can help your business achieve real results.